Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol-Reference-Cited by-同舟云学术

Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol

Published:2017-03-09 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Charaghvandi R. K.,van Asselen B.,Philippens M. E. P.,Verkooijen H. M.,van Gils C. H.,van Diest P. J.,Pijnappel R. M.,Hobbelink M. G. G.,Witkamp A. J.,van Dalen T.,van der Wall E.,van Heijst T. C.,Koelemij R.,van Vulpen M.,van den Bongard H. J. G. D.

Funder

Pink Ribbons Project (NL)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3144-5.pdf

Reference53 articles.

1. Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9.

2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.

3. Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.